|

Multiple Sclerosis Clinical Trials in Washington

16 recruiting studies across 1 city

Browse by City

Seattle
16 trials

All Trials in Washington

Phase
Trial Phase Dist.
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple SclerosisPhase 3<1 mi
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)N/A<1 mi
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple SclerosisPhase 3<1 mi
An Open-label Study of AZD0120 in Adults With Multiple SclerosisPhase 1<1 mi
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)Phase 1<1 mi
A Study of AZD0120 in Autoimmune DiseasesPhase 1<1 mi
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabPhase 3<1 mi
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention StudyPhase 2<1 mi
A Study of LY3541860 in Adult Participants With Relapsing Multiple SclerosisPhase 2<1 mi
Confirmatory Trial for Alleviating Fatigue in Multiple SclerosisN/A<1 mi
Factorial Optimization Trial to Test Cognitive Behavioral Therapy Components for Multiple Sclerosis FatigueN/A<1 mi
Non-invasive Electrical Spinal Cord Stimulation To Restore Upper Extremity Function in Multiple SclerosisPhase 1<1 mi
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)Phase 3<1 mi
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)—8 mi
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis SpasticityPhase 28 mi
Complementary and Alternative Care in Multiple Sclerosis—11 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.